Introduction
============

Benefits of central venous oxygen saturation (ScvO~2~) optimization, at early stages of severe sepsis and septic shock, have been shown \[[@B1]\]. Discontinuous ScvO~2~measurement has not been studied earlier. The purpose of our study was to compare continuous and discontinuous ScvO~2~in terms of the number of therapeutic interventions in septic patients.

Methods
=======

After approval by our institutional ethics committee, 16 patients with severe sepsis or septic shock were included in this prospective study. Patients were randomly assigned to the continuous ScvO~2~group (central venous catheter; Edwards Lifescience X3820HS) or to the discontinuous ScvO~2~group.

Blood pressure, heart rates and pulse oxymetry were continuously monitored and the lactate concentration measured in all patients. In both groups we noted that the number of therapeutic interventions due to the ScvO~2~value is \<70%. Statistical analysis used the Fisher test exact for qualitative variables and the Student *t*test (Mann--Whitney) for quantitative variables. *P*\< 0.05 was considered significant.

Results
=======

There were no significant differences between the groups with respect to baseline characteristics. The median number of therapeutic interventions was significantly higher in the continuous group (13 vs 7, *P*= 0.016). No significant differences ScvO~2~occurred between the length of stay in the two groups. See Table [1](#T1){ref-type="table"}.

###### 

Comparison between continuous and discontinuous central venous oxygen saturation

                              Continuous   Discontinuous   *P*value
  --------------------------- ------------ --------------- ----------
  Age                         63 ± 17      66.8 ± 5.6      0.64
  Weight                      63 ± 17      73 ± 8.9        0.44
  MODS                        6.62 ± 3.9   6.12 ± 1.8      0.87
  APACHE I                    18.8 ± 7.4   18.1 ± 6.8      0.87
  Length of stay              6.1 ± 2.51   10.2 ± 5        0.95
  Therapeutic interventions   13 (6˗19)    7 (4˗12)        0.01\*

\*Significant at *P*\< 0.05.

Conclusion
==========

These preliminary results showed that continuous ScvO~2~measurements increase the number of therapeutic interventions. We conclude that continuous measurement of ScvO~2~is helpful for early therapeutic interventions. Controlled trials of sufficient size, however, are needed to confirm these results.
